Literature DB >> 30230137

Treatable traits can be identified in a severe asthma registry and predict future exacerbations.

Vanessa M McDonald1, Sarah A Hiles1, Krystelle Godbout2, Erin S Harvey1,3, Guy B Marks4,5, Mark Hew6, Matthew Peters7, Philip G Bardin8, Paul N Reynolds9,10, John W Upham11,12, Melissa Baraket13, Zaheerodin Bhikoo14, Jeffrey Bowden15, Ben Brockway16, Li Ping Chung17, Belinda Cochrane18,19, Gloria Foxley5, Jeffrey Garrett20, Lata Jayaram21,22, Christine Jenkins7,23,24,25, Constance Katelaris19,26, Gregory Katsoulotos27, Mariko S Koh28,29, Vicky Kritikos30,31, Marina Lambert32, David Langton33,34, Alexis Lara Rivero27, Peter G Middleton35,36,37, Aldoph Nanguzgambo32, Naghmeh Radhakrishna6, Helen Reddel31, Janet Rimmer5,38, Anne Marie Southcott22, Michael Sutherland39, Francis Thien40, Peter A B Wark1,3, Ian A Yang41,42, Elaine Yap20, Peter G Gibson1,3.   

Abstract

BACKGROUND AND
OBJECTIVE: A new taxonomic and management approach, termed treatable traits, has been proposed for airway diseases including severe asthma. This study examined whether treatable traits could be identified using registry data and whether particular treatable traits were associated with future exacerbation risk.
METHODS: The Australasian Severe Asthma Web-Based Database (SAWD) enrolled 434 participants with severe asthma and a comparison group of 102 participants with non-severe asthma. Published treatable traits were mapped to registry data fields and their prevalence was described. Participants were characterized at baseline and every 6 months for 24 months.
RESULTS: In SAWD, 24 treatable traits were identified in three domains: pulmonary, extrapulmonary and behavioural/risk factors. Patients with severe asthma expressed more pulmonary and extrapulmonary treatable traits than non-severe asthma. Allergic sensitization, upper-airway disease, airflow limitation, eosinophilic inflammation and frequent exacerbations were common in severe asthma. Ten traits predicted exacerbation risk; among the strongest were being prone to exacerbations, depression, inhaler device polypharmacy, vocal cord dysfunction and obstructive sleep apnoea.
CONCLUSION: Treatable traits can be assessed using a severe asthma registry. In severe asthma, patients express more treatable traits than non-severe asthma. Traits may be associated with future asthma exacerbation risk demonstrating the clinical utility of assessing treatable traits.
© 2018 Asian Pacific Society of Respirology.

Entities:  

Keywords:  co-morbidity; exacerbation; registry; severe asthma; treatable traits

Mesh:

Year:  2018        PMID: 30230137     DOI: 10.1111/resp.13389

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  34 in total

1.  Exacerbation-Prone Asthma.

Authors:  Loren C Denlinger; Peter Heymann; Rene Lutter; James E Gern
Journal:  J Allergy Clin Immunol Pract       Date:  2019-11-22

Review 2.  Precision medicine and phenotypes, endotypes, genotypes, regiotypes, and theratypes of allergic diseases.

Authors:  Ioana Agache; Cezmi A Akdis
Journal:  J Clin Invest       Date:  2019-03-11       Impact factor: 14.808

Review 3.  Pulmonary rehabilitation versus usual care for adults with asthma.

Authors:  Christian R Osadnik; Ciara Gleeson; Vanessa M McDonald; Anne E Holland
Journal:  Cochrane Database Syst Rev       Date:  2022-08-22

4.  Management of severe asthma: from stepwise approach to therapy to treatable traits?

Authors:  Gang Wang; Vanessa M McDonald; Peter G Gibson
Journal:  Precis Clin Med       Date:  2021-12-03

5.  Body Composition-Specific Asthma Phenotypes: Clinical Implications.

Authors:  Xin Zhang; Ke Deng; Yulai Yuan; Lei Liu; Shuwen Zhang; Changyong Wang; Gang Wang; Hongping Zhang; Lei Wang; Gaiping Cheng; Lisa G Wood; Gang Wang
Journal:  Nutrients       Date:  2022-06-17       Impact factor: 6.706

6.  Characterisation of the Australian Adult Population Living with Asthma: Severe - Exacerbation Frequency, Long-Term OCS Use and Adverse Effects.

Authors:  Kerry L Hancock; Sinthia Bosnic-Anticevich; John D Blakey; Mark Hew; Li Ping Chung; Biljana Cvetkovski; Scott Claxton; Peter Del Fante; Eve Denton; Joe Doan; Kanchanamala Ranasinghe; Lucy Morgan; Anita Sharma; Peter K Smith; Deb Stewart; Philip J Thompson; Russell Wiseman; John W Upham; Kwok Y Yan; Victoria Carter; Kiranjeet Dhillon; Florian Heraud; Thao Le; Rebecca Vella; David Price
Journal:  Pragmat Obs Res       Date:  2022-07-05

7.  Treatable Mechanisms in Asthma.

Authors:  Mario Cazzola; Josuel Ora; Francesco Cavalli; Paola Rogliani; Maria Gabriella Matera
Journal:  Mol Diagn Ther       Date:  2021-02-11       Impact factor: 4.074

Review 8.  Oral corticosteroids stewardship for asthma in adults and adolescents: A position paper from the Thoracic Society of Australia and New Zealand.

Authors:  John Blakey; Li Ping Chung; Vanessa M McDonald; Laurence Ruane; John Gornall; Chris Barton; Sinthia Bosnic-Anticevich; John Harrington; Mark Hew; Anne E Holland; Trudy Hopkins; Lata Jayaram; Helen Reddel; John W Upham; Peter G Gibson; Philip Bardin
Journal:  Respirology       Date:  2021-09-29       Impact factor: 6.175

9.  The impact of severe asthma on patients' autonomy: A qualitative study.

Authors:  Daniela Eassey; Helen K Reddel; Kath Ryan; Lorraine Smith
Journal:  Health Expect       Date:  2019-03-21       Impact factor: 3.377

10.  Incidence and predictors of asthma exacerbations in middle-aged and older adults: the Rotterdam Study.

Authors:  Emmely W de Roos; Lies Lahousse; Katia M C Verhamme; Gert-Jan Braunstahl; Johannes J C C M In 't Veen; Bruno H Stricker; Guy G O Brusselle
Journal:  ERJ Open Res       Date:  2021-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.